tiprankstipranks
Trending News
More News >
Janux Therapeutics, Inc. (JANX)
:JANX
US Market

Janux Therapeutics Inc (JANX) Financial Statements

Compare
375 Followers

Janux Therapeutics Inc Financial Overview

Janux Therapeutics Inc's market cap is currently $1.44B. The company's EPS TTM is $-1.279; its P/E ratio is ―; Janux Therapeutics Inc is scheduled to report earnings on March 7, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 10.59M$ 8.08M$ 8.61M$ 3.64M$ 0.00
Gross Profit$ 10.59M$ 6.13M$ 7.77M$ 3.52M$ -13.00K
Operating Income$ -98.85M$ -72.98M$ -67.09M$ -32.93M$ -4.84M
EBITDA$ -98.85M$ -71.02M$ -66.25M$ -32.82M$ -4.83M
Net Income$ -68.99M$ -58.29M$ -54.15M$ -32.56M$ -5.25M
Balance Sheet
Cash & Short-Term Investments$ 1.03B$ 344.03M$ 327.02M$ 374.96M$ 7.81M
Total Assets$ 1.06B$ 380.41M$ 364.01M$ 379.82M$ 16.22M
Total Debt$ 23.02M$ 24.54M$ 25.30M$ 194.00K$ 0.00
Net Debt$ -407.58M$ 5.34M$ -26.12M$ -35.39M$ -7.81M
Total Liabilities$ 38.73M$ 36.06M$ 43.27M$ 13.50M$ 30.86M
Stockholders' Equity$ 1.02B$ 344.35M$ 320.74M$ 366.33M$ -14.64M
Cash Flow
Free Cash Flow$ -44.17M$ -52.42M$ -49.37M$ -18.46M$ -4.37M
Operating Cash Flow$ -43.81M$ -50.58M$ -42.92M$ -16.98M$ -4.37M
Investing Cash Flow$ -258.02M$ -41.19M$ 58.27M$ -340.96M$ 0.00
Financing Cash Flow$ 713.24M$ 59.55M$ 500.00K$ 386.52M$ 11.52M
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

Janux Therapeutics Inc Debt to Assets

Janux Therapeutics Inc Cash Flow

Janux Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis